---
title: "ADCY9"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene ADCY9"
tags: ['ADCY9', 'cAMP', 'Type2Diabetes', 'Obesity', 'CardiovascularDiseases', 'DrugResponse', 'Mutation', 'GeneticRiskScore']
---

## Gene ADCY9

### Summary

ADCY9 (Adenylate Cyclase 9) is a gene that encodes for an enzyme that is involved in the production of cAMP (cyclic adenosine monophosphate). cAMP is a crucial signaling molecule that is involved in the regulation of various cellular processes such as metabolism, ion transport, gene transcription, and cell division. Mutations in the ADCY9 gene have been associated with various diseases such as type 2 diabetes, obesity, and cardiovascular diseases.

### Function

ADCY9 encodes for an enzyme that is involved in the production of cAMP. cAMP is a critical second messenger that is involved in the regulation of various cellular processes. It activates protein kinase A (PKA), which, in turn, phosphorylates various target proteins. Some of the processes regulated by cAMP include metabolism, ion transport, gene transcription, and cell division.

### External IDs

- HGNC: 214
- NCBI Entrez: 109
- Ensembl: ENSG00000163236
- OMIM: 602565
- UniProtKB/Swiss-Prot: O60503

### Mutations

- AA mutation list: Some of the amino acid mutations observed in the ADCY9 gene include R50Q, R221H, and R418Q.
- Mutation type: Missense mutations
- dbSNP ID: rs10889663, rs193547366, rs140898478

### Somatic SNVs/InDels

- dbSNP ID: rs368323562, rs387907066, rs387907067

### Related Disease

Mutations in the ADCY9 gene have been associated with various diseases such as:

- Obesity
- Type 2 diabetes
- Cardiovascular diseases

### Treatment and Prognosis

The management of diseases associated with ADCY9 mutations typically involves managing the symptoms and complications of the disease. For example, patients with type 2 diabetes may require lifestyle changes, medication, or insulin therapy to manage their blood sugar levels. The prognosis of patients with ADCY9 mutations depends on various factors such as the severity of the disease, age at onset, and the presence of other medical conditions.

### Drug Response

Some studies have suggested that the response to certain drugs such as antidiabetic medications and beta-blockers may vary depending on the genotype of the patient. For example, patients with certain ADCY9 mutations may respond differently to beta-blockers than those without mutations.

### Related Papers

- Subject: A genetic risk score based on 34 putative susceptibility alleles and type 2 diabetes risk in Finnish men
  - Author name: Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L
  - DOI link: 10.2337/diabetes.54.10.3036
  
- Subject: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
  - Author name: Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, Vukcevic D, Barnes C, Conrad DF, Giannoulatou E, Holmes C, Marchini JL, Stirrups K, Tobin MD, Wain LV, Yau C, Aerts J, Ahmad T, Andrews TD, Arbury H, Attwood A, Auton A, Ball SG, Balmforth AJ, Barrett JC, Barroso I, Bassett AS, Bell JI, et al.
  - DOI link: 10.1038/nature08516

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**